<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
71861-0234-3
</NDCCode>
<PackageDescription>
88 TRAY in 1 CASE (71861-0234-3) / 20 SYRINGE, GLASS in 1 TRAY (71861-0234-2) / .67 mL in 1 SYRINGE, GLASS (71861-0234-1)
</PackageDescription>
<NDC11Code>
71861-0234-03
</NDC11Code>
<ProductNDC>
71861-0234
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Anakinra
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20201028
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Hospira Zagreb d.o.o.
</LabelerName>
<SubstanceName>
ANAKINRA
</SubstanceName>
<StrengthNumber>
100
</StrengthNumber>
<StrengthUnit>
mg/.67mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2026-03-28
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
28-OCT-20
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>